Literature DB >> 31734777

Low-dose glucocorticoid can lead to hypokalemic paralysis.

Sujin Ryu1, Tae Yang Yu2, Ha-Young Kim3, Chung Gu Cho1.   

Abstract

Glucocorticoids are widely used in clinical practice, and a rare adverse effect of glucocorticoid administration is hypokalemic paralysis. Recently, we experienced two cases of hypokalemic paralysis after low-dose glucocorticoid administration for urticaria in healthy men. Excluding possible endocrinologic disorders, we concluded that hypokalemic paralysis could be attributed to glucocorticoid administration in our patients. Only few cases of hypokalemic paralysis induced by relatively high glucocorticoid dose are reported. In our cases, we suggest that a very low dose of glucocorticoid injection results in hypokalemic paralysis, even in healthy individuals. Clinicians should be aware that a very low dose of glucocorticoid can cause hypokalemic paralysis. Furthermore, when evaluating patient complaints of muscle weakness with hypokalemia, history of glucocorticoid administration should be thoroughly reviewed.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31734777     DOI: 10.1007/s12020-019-02133-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  5 in total

1.  Betamethasone-induced hypokalemic periodic paralysis in pregnancy.

Authors:  Corey M Teagarden; Carla W Picardo
Journal:  Obstet Gynecol       Date:  2011-02       Impact factor: 7.661

2.  Abundance of Na(+)-K(+)-ATPase mRNA is regulated by glucocorticoid hormones in infant rat kidneys.

Authors:  G Celsi; A Nishi; G Akusjärvi; A Aperia
Journal:  Am J Physiol       Date:  1991-02

Review 3.  Hypertension and the cortisol-cortisone shuttle.

Authors:  Marcus Quinkler; Paul M Stewart
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

4.  Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans.

Authors:  B Ludvik; M Clodi; A Kautzky-Willer; M Capek; E Hartter; G Pacini; R Prager
Journal:  Diabetologia       Date:  1993-01       Impact factor: 10.122

5.  The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria.

Authors:  T Zuberbier; W Aberer; R Asero; A H Abdul Latiff; D Baker; B Ballmer-Weber; J A Bernstein; C Bindslev-Jensen; Z Brzoza; R Buense Bedrikow; G W Canonica; M K Church; T Craig; I V Danilycheva; C Dressler; L F Ensina; A Giménez-Arnau; K Godse; M Gonçalo; C Grattan; J Hebert; M Hide; A Kaplan; A Kapp; C H Katelaris; E Kocatürk; K Kulthanan; D Larenas-Linnemann; T A Leslie; M Magerl; P Mathelier-Fusade; R Y Meshkova; M Metz; A Nast; E Nettis; H Oude-Elberink; S Rosumeck; S S Saini; M Sánchez-Borges; P Schmid-Grendelmeier; P Staubach; G Sussman; E Toubi; G A Vena; C Vestergaard; B Wedi; R N Werner; Z Zhao; M Maurer
Journal:  Allergy       Date:  2018-07       Impact factor: 13.146

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.